Rick G. Schnellmann

5.7k total citations · 1 hit paper
81 papers, 4.4k citations indexed

About

Rick G. Schnellmann is a scholar working on Molecular Biology, Nephrology and Biochemistry. According to data from OpenAlex, Rick G. Schnellmann has authored 81 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 33 papers in Nephrology and 13 papers in Biochemistry. Recurrent topics in Rick G. Schnellmann's work include Acute Kidney Injury Research (29 papers), Chronic Kidney Disease and Diabetes (11 papers) and Mitochondrial Function and Pathology (10 papers). Rick G. Schnellmann is often cited by papers focused on Acute Kidney Injury Research (29 papers), Chronic Kidney Disease and Diabetes (11 papers) and Mitochondrial Function and Pathology (10 papers). Rick G. Schnellmann collaborates with scholars based in United States, Mexico and China. Rick G. Schnellmann's co-authors include Pallavi Bhargava, Jason A. Funk, Shougang Zhuang, Xiuli Liu, L. Jay Stallons, Kyle A. Rasbach, Grażyna Nowak, Terry Van Vleet, Jiahuai Han and Terry R. Van Vleet and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Rick G. Schnellmann

76 papers receiving 4.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial energetics in the kidney

2017 939 citations Pallavi Bhargava, Rick G. Schnellmann Nature Reviews Nephrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rick G. Schnellmann United States	32	2.2k	1.1k	535	521	491	81	4.4k
Toshiro Sugimoto Japan	41	2.1k 0.9×	1.5k 1.3×	784 1.5×	843 1.6×	324 0.7×	100	5.3k
Yves Gorin United States	41	2.4k 1.1×	1.2k 1.0×	369 0.7×	1.3k 2.5×	391 0.8×	61	5.8k
John S.D. Chan Canada	40	2.0k 0.9×	709 0.6×	337 0.6×	435 0.8×	231 0.5×	132	4.6k
Karen Block United States	35	2.0k 0.9×	775 0.7×	267 0.5×	946 1.8×	298 0.6×	47	4.5k
Feng Zheng China	38	1.1k 0.5×	598 0.5×	386 0.7×	579 1.1×	367 0.7×	74	3.6k
I. George Fantus Canada	36	2.2k 1.0×	549 0.5×	509 1.0×	903 1.7×	181 0.4×	66	4.5k
Zhanjun Jia China	35	2.0k 0.9×	1.0k 0.9×	426 0.8×	321 0.6×	541 1.1×	174	4.3k
Chengyuan Tang China	39	2.9k 1.3×	1.8k 1.6×	1.5k 2.8×	459 0.9×	925 1.9×	100	6.1k
Prabal K. Chatterjee United Kingdom	35	1.4k 0.7×	890 0.8×	250 0.5×	760 1.5×	684 1.4×	67	3.8k
Ming‐Zhi Zhang United States	38	1.5k 0.7×	855 0.8×	362 0.7×	487 0.9×	210 0.4×	83	4.1k

Countries citing papers authored by Rick G. Schnellmann

Since Specialization

Citations

This map shows the geographic impact of Rick G. Schnellmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick G. Schnellmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick G. Schnellmann more than expected).

Fields of papers citing papers by Rick G. Schnellmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick G. Schnellmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick G. Schnellmann. The network helps show where Rick G. Schnellmann may publish in the future.

Co-authorship network of co-authors of Rick G. Schnellmann

This figure shows the co-authorship network connecting the top 25 collaborators of Rick G. Schnellmann. A scholar is included among the top collaborators of Rick G. Schnellmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick G. Schnellmann. Rick G. Schnellmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thompson, Austin, et al.. (2025). Repurposing mitochondria-targeted therapeutics for kidney diseases. Kidney International. 107(4). 617–627. 2 indexed citations

Thompson, Austin, et al.. (2025). MC16 promotes mitochondrial biogenesis and ameliorates acute and diabetic nephropathy. British Journal of Pharmacology. 182(9). 1912–1929. 1 indexed citations

Scholpa, Natalie E., et al.. (2025). MARY1 restores mitochondrial homeostasis and accelerates renal recovery following acute kidney injury. American Journal of Physiology-Renal Physiology. 329(4). F411–F421.

Thompson, Austin, et al.. (2025). 5-Hydroxytryptamine 1F receptor loss reduces renal vasculature and prevents lasmiditan-induced recovery following moderate-severe acute kidney injury in mice. American Journal of Physiology-Renal Physiology. 329(6). F834–F852.

Liktor‐Busa, Erika, Kelly L. Karlage, Sheng‐Joue Young, et al.. (2024). Formoterol dynamically alters endocannabinoid tone in the periaqueductal gray inducing headache. The Journal of Headache and Pain. 25(1). 200–200.

Scholpa, Natalie E., et al.. (2024). Serotonin regulation of mitochondria in kidney diseases. Pharmacological Research. 203. 107154–107154. 8 indexed citations

Schnellmann, Rick G., et al.. (2023). Lasmiditan restores mitochondrial quality control mechanisms and accelerates renal recovery after ischemia–reperfusion injury. Biochemical Pharmacology. 218. 115855–115855. 8 indexed citations

Schnellmann, Rick G., et al.. (2023). 5-HT1F Agonist Lasmiditan Induces Mitochondrial Biogenesis And Alters Successful And Failed Repair Genes In A Mouse Model Of Acute Kidney Injury. Journal of Pharmacology and Experimental Therapeutics. 385. 501–501.

Schnellmann, Rick G., et al.. (2023). The β2-adrenergic receptor agonist formoterol restores mitochondrial homeostasis in glucose-induced renal proximal tubule injury through separate integrated pathways. Biochemical Pharmacology. 209. 115436–115436. 4 indexed citations

10.

Schnellmann, Rick G., et al.. (2022). Lasmiditan promotes recovery from acute kidney injury through induction of mitochondrial biogenesis. American Journal of Physiology-Renal Physiology. 324(1). F56–F63. 16 indexed citations

11.

Dupre, Tess V., et al.. (2019). The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cells. Biochemical Pharmacology. 169. 113644–113644. 25 indexed citations

12.

Bhargava, Pallavi & Rick G. Schnellmann. (2017). Mitochondrial energetics in the kidney. Nature Reviews Nephrology. 13(10). 629–646. 939 indexed citations breakdown →

13.

Smith, J. A., et al.. (2014). Suppression of Mitochondrial Biogenesis through Toll-Like Receptor 4–Dependent Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Signaling in Endotoxin-Induced Acute Kidney Injury. Journal of Pharmacology and Experimental Therapeutics. 352(2). 346–357. 60 indexed citations

14.

Blum, Jason L., Gilbert R. Kinsey, Prashant Monian, et al.. (2011). Profiling of fatty acids released during calcium-induced mitochondrial permeability transition in isolated rabbit kidney cortex mitochondria. Toxicology in Vitro. 25(5). 1001–1006. 10 indexed citations

15.

Rasbach, Kyle A. & Rick G. Schnellmann. (2006). Signaling of Mitochondrial Biogenesis following Oxidant Injury. Journal of Biological Chemistry. 282(4). 2355–2362. 141 indexed citations

16.

Liu, Xiuli & Rick G. Schnellmann. (2003). Calpain Mediates Progressive Plasma Membrane Permeability and Proteolysis of Cytoskeleton-Associated Paxillin, Talin, and Vinculin during Renal Cell Death. Journal of Pharmacology and Experimental Therapeutics. 304(1). 63–70. 72 indexed citations

17.

Liu, Xiuli, et al.. (2002). Cytoprotective Properties of Novel Nonpeptide Calpain Inhibitors in Renal Cells. Journal of Pharmacology and Experimental Therapeutics. 302(1). 88–94. 20 indexed citations

18.

Muralidhara, S., et al.. (2000). Contribution of Direct Solvent Injury to the Dose-Dependent Kinetics of Trichloroethylene: Portal Vein Administration to Rats. Toxicology and Applied Pharmacology. 164(1). 46–54. 9 indexed citations

19.

Schnellmann, Rick G., et al.. (1998). Proteases in renal cell death: Calpains mediate cell death produced by diverse toxicants. Renal Failure. 20(5). 679–686. 32 indexed citations

20.

Nowak, Grażyna & Rick G. Schnellmann. (1997). Renal Cell Regeneration Following Oxidant Exposure: Inhibition by TGF-β1and Stimulation by Ascorbic Acid. Toxicology and Applied Pharmacology. 145(1). 175–183. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact